Actively Recruiting

Phase Not Applicable
Age: 50Years +
All Genders
Healthy Volunteers
NCT06711952

German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)

Led by Ludwig-Maximilians - University of Munich · Updated on 2025-05-29

300

Participants Needed

1

Research Sites

134 weeks

Total Duration

On this page

Sponsors

L

Ludwig-Maximilians - University of Munich

Lead Sponsor

M

Medotrax UG

Collaborating Sponsor

AI-Summary

What this Trial Is About

The SCD-Q (Subjective Cognitive Decline-Questionnaire) is an established instrument to quantify self-perceived cognitive decline. Both self- and informant-rated versions of the SCD-Q are available. However, the SCD-Q has not been validated in the German language yet. Hence, the investigators aim to validate the self-reported SCD-Q in a clinical sample in Germany.

CONDITIONS

Official Title

German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)

Who Can Participate

Age: 50Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Medical appointment for dementia diagnostics at the Alzheimer Therapie- und Forschungszentrum
  • Signed, written and dated informed consent provided
  • Capacity to give informed consent
Not Eligible

You will not qualify if you...

  • Dementia in a very advanced stage
  • Illiteracy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU Klinikums

München, Bavaria, Germany, 80336

Actively Recruiting

Loading map...

Research Team

C

Carolin Kurz, Dr.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SCREENING

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here